In This Section

Newsroom

  • Dr. Daly Memorial

    Remembering John M. Daly, MD ’73, FACS (1947 -2021)

    During the past few weeks, gatherings both somber and sweet took place at Temple to mourn and celebrate John M. Daly, MD ’73, FACS, the masterful, much-loved, two-time Lewis Katz School of Medicine dean who died March 26. Some of the events were small, some were large, and all were moving. 

  • Dr. Kunapuli

    With New 7-Year, Multi-Million Dollar NIH Grant, Temple Scientists Take Deep Dive Into Molecular Causes of Abnormal Clotting in Cardiovascular Disease

    ​More than two decades of research on how platelets in the blood become activated and stick together to form clots has given Satya P. Kunapuli, PhD, Professor of Physiology, Professor of Pharmacology and Director of the Sol Sherry Thrombosis Research Center at the Lewis Katz School of Medicine at Temple University, extensive insight into the role of abnormal clot formation in cardiovascular disease

  • Skorski

    Aging During COVID-19

    The COVID-19 pandemic has had a devastating impact on America’s older adults, with eight out of every ten COVID-19 deaths occurring in people 65 and older. For that reason, the Fels Cancer Institute for Personalized Medicine at the Lewis Katz School of Medicine chose to make the intersection of aging and COVID-19 the theme of its third annual mini symposium on aging, held virtually this year on May 7. 

  • Temple Hospital and Medical School

    Temple University Hospital Named Most Racially Inclusive Hospital in PA and One of Most Racially Inclusive Hospitals in the U.S. by Lown Institute

    Temple University Hospital has been ranked the most racially inclusive hospital in Pennsylvania and the 13th most racially inclusive hospital in the United States by the Lown Institute, a nonpartisan health care think tank.

  • Margaret Barnes

    Lewis Katz School of Medicine’s Center for Urban Bioethics Receives $1 Million Legacy Bequest and $50,000 Donation from Dr. Margaret Barnes

    Margaret M. Barnes, MD, a 1981 graduate of the Lewis Katz School of Medicine at Temple University and a radiation oncologist certified in hospice and palliative care medicine, has chosen the school’s Center for Urban Bioethics as the recipient of a $1 million legacy bequest and a $50,000 donation.

  • Awards Day 2021

    The Lewis Katz School of Medicine Celebrates Outstanding Faculty Members and Students during Awards Day

    On Thursday, May 6, 2021, the Lewis Katz School of Medicine held its annual Awards Day to honor outstanding faculty members and student achievements. The event was virtually streamed on the LKSOM YouTube Channel. Friends and families from near and far celebrated the skilled teachers and the talented physician and researcher candidates who made up this year's honorees. The philanthropic nature of Awards Day was also on display, as many of the awards were established by generous donors to recognize and celebrate traditions of excellence in the classroom, lab, and clinic. 

  • Class of 2021

    Congratulations, Class of 2021!

    The Lewis Katz School of Medicine Class of 2021 celebrated its graduation — the School’s 119th commencement — under partly sunny skies on May 7 at the Temple Sports Complex, an outdoor athletic field on the University’s main campus, with the graduates sitting six feet apart from one another,and with presiding faculty and administrators occupying a stage beneath a tent at the side of the field. Everyone wore a mask. The graduates’families and friends watched a livestream of the ceremony on the School’s YouTube channel. More than a thousand viewers logged into the broadcast. Altogether over 200 students were awarded MD, MA, MS,and/or PhD degrees, some in combination.

  • Dr. John Elrod

    Temple Researchers Poised to Gain Insight into Biological Underpinnings of Alzheimer’s Disease Thanks to NIH Grant

    Thanks to a new three-year, $2.27 million grant from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, Dr. John Elrod and colleagues are poised to gain novel insight into biological mechanisms that may be driving or worsening neurodegeneration. The researchers will investigate potential mechanisms using mouse models of Alzheimer’s disease and a systems biology approach. The work could help identify new drug targets and therapeutic opportunities for Alzheimer’s disease.

Pages